Replenza Daily Replenisher
US$ 21.07
glp-1 agonist cardiovascular outcomes in major trials with receptor agonists The Big Trial of a
Description
[DOI] [PubMed] [Google Scholar] 43.Frias JP, et al
These findings suggest varied psychiatric risks associated with different GLP-1 RA medications, with Wegovy demonstrating the highest risk for conditions such as major depressive disorder and anxiety
10.1186/s12902-024-01775-2 69 SommE.MontandonS
The neurological basis for GLP-1s effects on appetite regulation involves the importance of gut vs
Holst, Smidt Gasberg, Rosenkilde
Additionally, a doseresponse relationship has also been noted with specific agents
